Abstract
The 5-year survival (n = 98) was found to be of 37%. The 5-year survival of patients in perioperative chemotherapy group (n = 75) was 44% while those who had a curative resection (n = 73) had a survival of 46%. Statistically significant difference was present for the actual number of observed mortalities for patients with poorly differentiated carcinoma (p = 0.005) and extranodal extension (p = 0.002). Conclusion: Gastric adenocarcinoma is an aggressive disease. Perioperative chemotherapy works well in Pakistani population as the results at our institution are comparable with international data Reference(s)
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
